Cargando…
Group testing can improve the cost-efficiency of prospective-retrospective biomarker studies
BACKGROUND: Cancer treatment is increasingly dependent on biomarkers for prognostication and treatment selection. Potential biomarkers are frequently evaluated in prospective-retrospective studies in which biomarkers are measured retrospectively on archived specimens after completion of prospective...
Autores principales: | Zhang, Wei, Zhang, Zhiwei, Krushkal, Julia, Liu, Aiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977501/ https://www.ncbi.nlm.nih.gov/pubmed/33740890 http://dx.doi.org/10.1186/s12874-021-01239-4 |
Ejemplares similares
-
Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies
por: Crespo, Carlos, et al.
Publicado: (2014) -
Modified enzyme multiplied immunoassay technique of methotrexate assay to improve sensitivity and reduce cost
por: Shi, Xiaoping, et al.
Publicado: (2019) -
Group testing performance evaluation for SARS-CoV-2 massive scale screening and testing
por: Nalbantoglu, Ozkan Ufuk
Publicado: (2020) -
Efficient clinical evaluation of guideline quality: development and testing of a new tool
por: Grimmer, Karen, et al.
Publicado: (2014) -
An improved, versatile and efficient modular plasmid assembly system for expression analyses of genes in Xanthomonas oryzae
por: Zou, Lifang, et al.
Publicado: (2021)